Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases. - Wikidata - awgldk - TriplyDB

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

http://www.wikidata.org/entity/Q33586412

about

Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.Metabotropic glutamate receptors in cancer.The silver jubilee: Journal of Child Neurology turns 25.

P2860

Q37121338-F04C9416-E421-4745-AA77-D130EAC2CEE2 Q38741884-E7777CF5-8EA8-4C94-AEC3-391C69CB0E84 Q48924888-57FAD796-4BC5-4F3A-BBE6-F6B0D5099249

P2860

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

http://www.wikidata.org/entity/Q33586412

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@ast

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@en

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@nl

type

label

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@ast

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@en

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@nl

prefLabel

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@ast

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@en

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@nl

P1433

Q33586412-4765F44E-8795-4525-9A53-87851ADA5249

P1476

Q33586412-45C765E4-F500-47A1-BC46-DDDBB0436DD5

P2093

Q33586412-62CE84A6-0A6B-4998-A5CA-5D8749920900

P2860

Q33586412-062E1784-51E6-481E-9A13-923CE18E44EA

Q33586412-2C8AC207-D1EF-4D38-BEDE-2CA70472F631

Q33586412-2EF5124E-6219-4C0B-92A6-6EF801DFF3E6

Q33586412-34E2411B-F7CD-4881-B161-B6381E7312D2

Q33586412-48D35BDD-4604-4852-8346-FB3D6E303527

Q33586412-491274AB-EEDE-450E-B5BE-FD95B0E74F4D

Q33586412-52E2C3E9-30C5-4044-81A9-127B1EA26EDF

Q33586412-56ECD59E-2723-4BA3-AB2B-395F74DC665F

Q33586412-6C1AC10C-711F-4918-A2C4-56508A08F5CA

Q33586412-710F8C4E-FB06-4FD2-BF88-8CF147D45907

P304

Q33586412-7B0FA17F-9F5B-424B-9135-399307988D72

P31

Q33586412-5F2CAC0A-75D6-4C07-B4AB-63986476BDEF

P356

Q33586412-5E9A3001-46AE-474A-9B3E-754A3F0AA095

P433

Q33586412-3297257D-76FE-4806-8FAC-609E5E48FB70

P478

Q33586412-A8FC056A-28D6-409C-85D2-FB69C2717876

P577

Q33586412-55CEE268-592C-4E85-BECF-95B14091211F

P698

Q33586412-05CB9197-9E67-4E50-A048-CF7F8358DED2

P356

088307389901400308

P1433

Journal of Child Neurology

P1476

Carrell-Krusen Symposium invited lecture. Clinical trials in motor neuron diseases.

@en

P2093

R G Miller

http://www.w3.org/2001/XMLSchema#string

P2860

The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy

The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins

Spinal muscular atrophy

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3

Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential

Identification and characterization of a spinal muscular atrophy-determining gene

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene.

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.

P304

173-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/088307389901400308

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10190269

http://www.w3.org/2001/XMLSchema#string